13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • FOLLOW IT

    Acronym: 

    ACTRN/NCT /ethics: 

    Scientific title: 

    Clinical validation of circulating tumour DNA (ctDNA) mutation analysis by targeted NGS testing using FOLLOW IT in patients with solidtumours

    Summary of trial and patient characteristics

    Cancer Type All cancers
    Trial Type Treatment
    Phase All phases Tumour Stream Solid tumours
    Age Range 18 years and older Cancer Stage
    Sex Both Anticipated Start Date
    Molecular Target Anticipated End Date
    Cancer Type All cancers
    Trial Type Treatment
    Phase All phases
    Age Range 18 years and older
    Sex Both
    Molecular Target
    Tumour Stream Solid tumours
    Cancer Stage
    Anticipated Start Date
    Anticipated End Date

    Trial Summary

    Clinical validation of circulating tumour DNA (ctDNA) mutation analysis by targeted NGS testing using “FOLLOW IT” in patients with solid tumours

    Lay Summary

    Clinical validation of circulating tumour DNA (ctDNA) mutation analysis by targeted NGS testing using FOLLOW IT in patients with solidtumours

    Sponsor / Cooperative group

    Sonic Genetics

    Participating Hospitals

    Hospital Clinical Trial Coordinator Email Phone Principal Investigator Recruitment Status
    Ashford Cancer Centre Research Sue Yeend syeend@adelaidecancercentre.com.au 08 8292 2240 Recruiting